Results 251 to 260 of about 152,669 (311)

Characterization of KLK5-high epithelial cells and their interactions with the tumor microenvironment in high-grade serous ovarian cancer. [PDF]

Cancer Cell Int
Wang Z, Ding L, Zhu Q, Ou Q, Wang Q, Xie Y, Li L, Liu X, Ni C, Wang Y, Liu Y, Yu L, Cai J, Gao L.   +13 more
europepmc   +1 more source

MRI Findings of Ovarian Carcinosarcoma: A Retrospective Comparison With Endometrioid Carcinoma. [PDF]

Cureus
Tashiro A, Okuma T, Yamaguchi T, Honjo T, Inoue N, Okajima S, Murakami M, Ichimura T.   +7 more
europepmc   +1 more source

Hiding in plain sight: DICER1‐associated yolk sac tumour masquerading as an endometrioid carcinoma of the ovary

Histopathology, EarlyView.
Lili Fu, Afrida Ahmed, Celine Domecq, Elizabeth N Skinner, William D Foulkes   +4 more
wiley   +1 more source

Synchronous primary HPV-associated squamous cell carcinomas of the cervix and fallopian tube: a case report. [PDF]

Front Oncol
Lu J, Chen C, Bai Y, Kang M.
europepmc   +1 more source

Prognostic influence of small leucine-rich proteoglycans on serous ovarian cancer. [PDF]

J Cancer Res Clin Oncol
Surmann H, Bartha A, Győrffy B, Kiesel L, Hanker L, Götte M.   +5 more
europepmc   +1 more source

[Retracted] Novel triazole analogs of apigenin-7-methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial-mediated apoptosis. [PDF]

Exp Ther Med
Qi Y, Ding Z, Yao Y, Ma D, Ren F, Yang H, Chen A.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epithelial Ovarian Carcinoma and Fertility of Parents

Epidemiology, 2002
We studied the fertility of the parents of 163 women with epithelial ovarian carcinoma in two hospitals in New York City, compared with the parents of 159 controls from similar neighborhoods. We used unconditional logistic regression to control for covariates, including parity, oral contraceptive use, age at menarche, and Jewish ancestry. Compared with
Siskind, Victor, Purdie, David, Whiteman, David, Green, Adele   +3 more
  +7 more sources

Epithelial ovarian carcinoma

The Lancet, 1997
The low survival rate is related to the high proportion of women who have spread of disease beyond the ovaries at diagnosis—25%, 11%, 47%, and 17% of cases at stage I‐IV, respectively, according to International Federation of Gynaecological and Obstetrics (FIGO) staging ...
G B, Kristensen, C, Tropé
openaire   +2 more sources

Farletuzumab in epithelial ovarian carcinoma

Expert Opinion on Biological Therapy, 2010
Ovarian cancer is the leading cause of death from a gynecologic malignancy. Recurrence is both common and lethal, necessitating the development of novel targeted therapies. Farletuzumab (MORAb-003) is a humanized mAb with high affinity for folate receptor alpha (FRalpha), a 38 kDa GPI-anchored protein that is overexpressed in 90% of epithelial ovarian ...
Whitney A, Spannuth, Anil K, Sood, Robert L, Coleman   +2 more
openaire   +2 more sources